Official recall notice

FDA DrugClass IINotable

Carbamazepine Tablets Recall (Aug 2026)

Product: Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA

Recall date
2026-08-26
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

CGMP deviations: tablets with black specks.

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

CGMP deviations: tablets with black specks.

Affected products

Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028

Verify with the official notice →
Share:

Related Recalls

2026-09-09 · FDA_DRUG
FDA Recall: Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camari
Golden State Medical Supply Inc.
2026-06-17 · FDA_DRUG
FDA Recall: GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured
Golden State Medical Supply Inc.
2026-05-27 · FDA_DRUG
FDA Recall: Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., M
Golden State Medical Supply Inc.
2026-05-27 · FDA_DRUG
FDA Recall: Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Mar
Golden State Medical Supply Inc.